Tpl2-IN-34

CAS No. 915363-56-3

Tpl2-IN-34( Tpl2 inhibitor 34 | MAP3K8-IN-34 )

Catalog No. M16575 CAS No. 915363-56-3

A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 181 In Stock
5MG 152 In Stock
10MG 242 In Stock
25MG 511 In Stock
50MG 737 In Stock
100MG 1051 In Stock
200MG 1414 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tpl2-IN-34
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.
  • Description
    A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM; dispalys 6875-fold selectivity over EGFR. P38, Src, CAMKII, MK2, PKA, and PKC (IC50>10 uM); inhibits LPS-induced TNF-α production in whole blood with IC50 of 0.3 uM; shows good efficacy in inhibiting TNF-alpha production in a LPS-stimulated rat inflammation model; orally active.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tpl2 inhibitor 34 | MAP3K8-IN-34
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    915363-56-3
  • Formula Weight
    539.4347
  • Molecular Formula
    C26H25Cl2FN8
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCN1CCC(CC1)N2C=C(N=N2)CNC3=CC4=C(C(=CN=C4C(=C3)Cl)C#N)NC5=CC(=C(C=C5)F)Cl
  • Chemical Name
    3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wu J, et al. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3485-8.
molnova catalog
related products
  • MKK7-COV-3

    MKK7-COV-3 (MKK7 Covalen inhibitor 3) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 5 nM.

  • DLK-IN-14

    A potent, selective, CNS penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of 3 nM.

  • Refametinib

    A potent, non–ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.